ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,930.85
      1.09%
      US Tech 100
      20,743.20
      -0.02%
      Dow Jones
      42,840.26
      1.18%
      Brent Oil
      72.375
      -0.47%
      Bitcoin
      95,779.04
      0.70%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Abliva Ab (0QDU) Quote

      Abliva Ab

      Abliva Ab (0QDU)

      LSE
      2.65
      0.00
      ( 0.00% )
      Updated: 19:00:00
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      2.65
      Bid
      0.00
      Ask
      0.00
      Volume
      0.00
      0.00 Day's Range 0.00
      2.65 52 Week Range 2.65
      Market Cap
      2.799B
      Previous Close
      2.65
      Open
      -
      Last Trade
      (O)
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      5,499
      Shares Outstanding
      1,056,299,000
      Dividend Yield
      -
      PE Ratio
      -0.44
      Earnings Per Share (EPS)
      -0.09
      Revenue
      137k
      Net Profit
      -95.51M

      About Abliva Ab

      Sector
      Med, Dental, Hosp Eq-whsl
      Industry
      Med, Dental, Hosp Eq-whsl
      Website
      www.abliva.com
      Headquarters
      Lund, Swe
      Founded
      -
      Abliva Ab is listed in the Med, Dental, Hosp Eq-whsl sector of the London Stock Exchange with ticker 0QDU. The last closing price for Abliva Ab was SEK2.65. Over the last year, Abliva Ab shares have traded in a share price range of SEK 2.65 to SEK 2.65.

      Abliva Ab currently has 1,056,299,000 shares outstanding. The market capitalization of Abliva Ab is SEK2.80 billion. Abliva Ab has a price to earnings ratio (PE ratio) of -0.44.

      Ask ADVFN Intelligence (AI)

      0QDU Latest News

      More News

      NeuroVive Pharmaceutical AB Year End Report January - December 2019

      NeuroVive Pharmaceutical AB Year End Report January - December 2019 PR Newswire STOCKHOLM, Feb. 19, 2020 STOCKHOLM, Feb. 19, 2020 /PRNewswire/ -- Important events in 2019 KL1333           ...

      February 19 2020
      PR Newswire (US)

      NeuroVive Pharmaceutical AB Year End Report January - December 2019

      NeuroVive Pharmaceutical AB Year End Report January - December 2019 PR Newswire STOCKHOLM, Feb. 19, 2020 STOCKHOLM, Feb. 19, 2020 /PRNewswire/ -- Important events in 2019 KL1333           ...

      February 19 2020
      PR Newswire (US)

      NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study

      NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study PR Newswire LUND, Sweden, Dec. 20, 2019 LUND, Sweden, Dec. 20, 2019 /PRNewswire/ -- NeuroVive...

      December 20 2019
      PR Newswire (US)

      NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study

      NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study PR Newswire LUND, Sweden, Dec. 20, 2019 LUND, Sweden, Dec. 20, 2019 /PRNewswire/ -- NeuroVive...

      December 20 2019
      PR Newswire (US)

      NeuroVive Announces Settlement in Dispute With CicloMulsion AG

      NeuroVive Announces Settlement in Dispute With CicloMulsion AG PR Newswire LUND, Sweden, Dec. 16, 2019 LUND, Sweden, Dec. 16, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm:...

      December 16 2019
      PR Newswire (US)

      NeuroVive Announces Settlement in Dispute With CicloMulsion AG

      NeuroVive Announces Settlement in Dispute With CicloMulsion AG PR Newswire LUND, Sweden, Dec. 16, 2019 LUND, Sweden, Dec. 16, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm:...

      December 16 2019
      PR Newswire (US)

      NeuroVive Pharmaceutical AB Interim Report January - September 2019

      NeuroVive Pharmaceutical AB Interim Report January - September 2019 PR Newswire STOCKHOLM, Nov. 20, 2019 - Continued Progress in KL1333 STOCKHOLM, Nov. 20, 2019 /PRNewswire/ -- Important...

      November 20 2019
      PR Newswire (US)

      NeuroVive Pharmaceutical AB Interim Report January - September 2019

      NeuroVive Pharmaceutical AB Interim Report January - September 2019 Continued Progress in KL1333 PR Newswire STOCKHOLM, Nov. 20, 2019 STOCKHOLM, Nov. 20, 2019 /PRNewswire/ -- Important events...

      November 20 2019
      PR Newswire (US)

      NeuroVive Pharmaceutical AB Interim Report January - June 2019

      NeuroVive Pharmaceutical AB Interim Report January - June 2019 PR Newswire STOCKHOLM, Aug. 21, 2019 Focus on genetic mitochondrial diseases STOCKHOLM, Aug. 21, 2019 /PRNewswire/ -- Important...

      August 21 2019
      PR Newswire (US)

      NeuroVive Pharmaceutical AB Interim Report January - June 2019

      NeuroVive Pharmaceutical AB Interim Report January - June 2019 Focus on genetic mitochondrial diseases PR Newswire STOCKHOLM, Aug. 21, 2019 STOCKHOLM, Aug. 21, 2019 /PRNewswire/ -- Important...

      August 21 2019
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1002.652.652.65330782.65DE
      4002.652.652.65131332.65DE
      12002.652.652.6554992.65DE
      26002.652.652.6527082.65DE
      52002.652.652.6514372.65DE
      156002.652.652.6516862.65DE
      260002.652.652.6515532.65DE

      0QDU - Frequently Asked Questions (FAQ)

      What is the current Abliva Ab share price?
      The current share price of Abliva Ab is SEK 2.65
      How many Abliva Ab shares are in issue?
      Abliva Ab has 1,056,299,000 shares in issue
      What is the market cap of Abliva Ab?
      The market capitalisation of Abliva Ab is SEK 2.8B
      What is the 1 year trading range for Abliva Ab share price?
      Abliva Ab has traded in the range of SEK 2.65 to SEK 2.65 during the past year
      What is the PE ratio of Abliva Ab?
      The price to earnings ratio of Abliva Ab is -0.44
      What is the cash to sales ratio of Abliva Ab?
      The cash to sales ratio of Abliva Ab is 400
      What is the reporting currency for Abliva Ab?
      Abliva Ab reports financial results in SEK
      What is the latest annual turnover for Abliva Ab?
      The latest annual turnover of Abliva Ab is SEK 137k
      What is the latest annual profit for Abliva Ab?
      The latest annual profit of Abliva Ab is SEK -95.51M
      What is the registered address of Abliva Ab?
      The registered address for Abliva Ab is MEDICON VILLAGE, SCHEELEVAGEN 2, LUND, 223 81
      What is the Abliva Ab website address?
      The website address for Abliva Ab is www.abliva.com
      Which industry sector does Abliva Ab operate in?
      Abliva Ab operates in the MED, DENTAL, HOSP EQ-WHSL sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      GRLGoldstone Resources Limited
      1.40p
      (51.35%)
      		7.8M
      INDIIndus Gas Limited
      10.10p
      (36.95%)
      		475.63k
      ZENZenith Energy Ltd.
      3.30p
      (35.25%)
      		2.92M
      PRMProteome Sciences Plc
      3.60p
      (29.50%)
      		441.25k
      BODBotswana Diamonds Plc
      0.205p
      (28.13%)
      		3.45M
      QUIZQuiz Plc
      0.90p
      (-60.35%)
      		11.02M
      TRYBTribe Technology Plc
      0.075p
      (-34.78%)
      		888.76k
      PFCPetrofac Limited
      8.80p
      (-13.73%)
      		10.78M
      GEMGemfields Group Limited
      6.25p
      (-12.59%)
      		2.04M
      OMIOrosur Mining Inc
      7.25p
      (-12.12%)
      		2.68M
      NTVONativo Resources Plc
      0.002p
      (-9.09%)
      		1.84B
      TRPTower Resources Plc
      0.035p
      (0.00%)
      		280.79M
      PREMPremier African Minerals Limited
      0.0485p
      (0.00%)
      		98.38M
      BCEBeacon Energy Plc
      0.0045p
      (20.00%)
      		80.22M
      MSMNMosman Oil And Gas Limited
      0.0295p
      (-1.67%)
      		68.89M

      Discussion

      View Full Feed
      canthelpit canthelpit 4 minutes ago
      GTCH could we get a CHRISTMAS miracle and see a 3 - 4 bid today to get some momentum going into the holidays and bring us into the new year on a positive note .... I asked SANTA and he said he would see what he could do LOL GLTA
      GTCH
      Risk vs Reward Risk vs Reward 5 minutes ago
      Just starting to check this company out. Nice SS and looks promising!
      MVNC
      tw0122 tw0122 6 minutes ago
      CTM .70 + 16% 
      CTM
      luvwetscent luvwetscent 7 minutes ago
      Ohhhh..that explains why he lies
      ELTP
      nwsun nwsun 7 minutes ago
      It's not that far to 0001 as it is.
      INKW
      tw0122 tw0122 8 minutes ago
      Cash out most 1.86
      LYT
      primecomm primecomm 9 minutes ago
      $TNXP Explosion Imminent $$$$$$$$$$$
      TNXP
      tw0122 tw0122 9 minutes ago
      1.90 + 81% 
      LYT
      primecomm primecomm 9 minutes ago
      MM's holding it down but not for long.
      TNXP
      tw0122 tw0122 10 minutes ago
      1.77 +72% up more
      LYT
      Iggy_Bot Iggy_Bot 10 minutes ago
      Lawsuit If he is not well enough to stand trial, how is he well enough to be doing this
      (SHUNNED) (SHUNNED) 11 minutes ago
      Oh yeah ! Fun for all and all for fun ! 
      GMGI
      tw0122 tw0122 11 minutes ago
      LYT back to 1.05 at $1.50 + 40% 
      LYT
      Hi_Lo Hi_Lo 12 minutes ago
      And how many criminal charges have been brought against Jason Black and Jason Tucker during those over half a decade deep probes?
      Jason Black and Jason Tucker are still in cahoots with Mark Miller (convicted felon) via Capitol Capital Corporation. They just haven't been indicted yet. The SEC
      CNNA
      flipper44 flipper44 13 minutes ago
      Tale of Two “Bears.” So I assume you are Exwannabe’s default.

      Exwannabe gave/gives DCVax-l ”1%” chance of approval w/o further trial.

      Investor02 assumes approval will occur but gave/gives ”1%” chance of non-dilutive funds from a Big Pharma in first quarter.
      NWBO
      Wolf-man jack Wolf-man jack 13 minutes ago
      WQLF SAYS;

      https://www.lunarfoxfoods.com/

      https://veggs.eu/


      https://tsdr.uspto.gov/#caseNumber=98388857&caseSearchType=US_APPLICATION&caseType=DEFAULT&searchType=statusSearch
      CVSI
      elks elks 16 minutes ago
      Good morning.
      TNXP
      baltimorebullet baltimorebullet 16 minutes ago
      Or it could all go badly.
      Not trying to be Captain Negative but change always comes with a price.
      AVXL
      ksquared ksquared 18 minutes ago
      The Sanctuary State Migrant Boom
      The latest Census report shows that foreign migration in the last year offset domestic flight in California, New York and other Democratic-run states.
      By The Editorial Board Dec. 22, 2024 4:50 pm ET

      Are Democrats in self-declared sanctua
      arachnodude arachnodude 18 minutes ago
      This year, we achieved what many thought impossible: the successful transition from innovation to production, unlocking the full potential of spider silk as a game-changing material. The introduction of our BAM-1 production hybrids was nothing short of transformative, propelling us into large-scale,
      KBLB
      tw0122 tw0122 20 minutes ago
      Time to exit 
      RELI
      tw0122 tw0122 21 minutes ago
      4.40 + 270%
      RELI
      tw0122 tw0122 24 minutes ago
      $4.11 + 242%
      RELI
      tw0122 tw0122 25 minutes ago
      Small Monday pump 
      RELI
      Risk vs Reward Risk vs Reward 25 minutes ago
      Usually the week between Christmas 🎄 and New Years is boring and futile, guess we'll see if KULR NATION thinks differently 
      KULR

      Your Recent History

      LSE
      0QDU
      Abliva Ab
      TG
      A19Q53
      Prudential
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads